Capvizr

WISE Raises $30 million Series D

Company profile · Healthcare & Life Sciences · Updated June 17, 2026

WISE has raised $30M in Series D funding. Wise hints at stablecoin ambitions with new digital-asset product lead search The funds will be used to Support neurostim tech - MassDevice.

Series D$30 millionTotal tracked $730 millionUndisclosed HQ

What it does

Capvizr has a factual funding record for this company, but source material is too thin for MD-grade operating analysis.

Traction

WISE is continuing to scale after securing $30M in Series D funding.

Trend impact

MD-grade thesis held: available source material is not specific enough to support a non-generic investor-economist read without overclaiming.

Funding history

  • June 17, 2026 · Series D · $30 million · undisclosed investors
  • Recent · IPO · $700 million · Various

Products & services

  • Million, Welcoming ENEA Tech and Biomedical as Strategic New Investor capability
  • Via TT Wise’s Cross-Border Payments Are Its Fastest-Growing Business - capability
  • PaymentsJournal. Wise’s Cross-Border Payments Are Its Fastest-Growing capability
  • Business - PaymentsJournal capability
  • PaymentsJournal Wise hints at stablecoin ambitions with new digital- capability
Open Wise in the interactive Capvizr dashboard →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime